BioSpace News Archive

Ikonopedia announced today that Intermountain Healthcare, based in Salt Lake City, Utah , has selected the company’s structured breast reporting and risk assessment tools to help improve reporting quality, efficiency, and maintain patient safety. The system-wide implementation will be initiated at six Intermountain Healthca

The Board of Directors of Moog Inc. has declared a quarterly dividend of $.25 per share on the Company’s issued and outstanding shares of Class A common stock and Class B common stock.

Gilead and Galapagos Announce Positive European CHMP Opinion for Jyseleca ® (Filgotinib) for the Treatment of Adults With Moderate to Severe Rheumatoid Arthritis -- Clinical Development Program of Filgotinib Demonstrated Durable Efficacy Balanced with a Consistent Safety Profile in Rheumatoid Arthritis Through 52 Weeks -- FOSTER CITY, Calif., & MECHELEN, Belgium--( BUSINESS WIRE )-- Gilead Sciences, Inc. (Nasdaq: GILD) and Galapagos NV (Euronex

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to SRP-9001 (AAVrh74.MHCK7.micro-dystrophin). SRP-9001 is an investigational gene transfer therapy intended to deliver its micro-dystrophin-encoding gene to muscle tissue for the targeted production of the micro-dystrophin protein. Safety and

Unicity International, a leader in metabolic health solutions, has been issued a US patent for an innovative process in its OmegaLife-3 Resolv supplement: US Pat. No. 10,624,907 B2. Unicity Int

Dr. Arthur Castelbaum of RMA Philadelphia joins leadership developing best practice protocols for diagnosing and treating infertile couples.

Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune/inflammatory diseases, today announced it has entered into a definitive securities purchase agreement for the sale of common units and prefunded warrant units, as described below, in a private placement with certain institutional and other accredited investors for gross

Annexon, Inc. announced the pricing of its initial public offering of 14,750,000 shares of its common stock at a public offering price of $17.00 per share.

The telehealth market is riding on the wave of growth. This is because telehealth is no longer an option, but a necessity due to the increasing dangers of COVID-19.

Mobile technology has expanded significantly across the globe in recent years.